The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?

The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?

When evaluating the effect of therapy for malignant neoplasms with inhibitors of CTLA-4, PD-1 and PD-L1, the phenomenon of pseudoprogression may occur. Pseudoprogression is an increase in the volume of tumor tissue due to immunocompetent cells (lymphocytes, macrophages) mobilized into the tumor focu...

Full description

Saved in:
Bibliographic Details
Main Authors: Vladislav O. Sarzhevskiy, Vladimir Ia. Melnichenko, Irina V. Panshina, Nikita E. Mochkin, Vladimir S. Bogatyrov, Maria M. Borshevetskaya, Elena G. Smirnova, Anna E. Bannikova, Anastasia A. Samoylova, Aysel A. Mamedova, Anatolij A. Rukavitsin, Sergei S. Vasilev, Oleg Iu. Bronov
Format: article
Language:RU
Published: IP Habib O.N. 2021
Subjects:
immunotherapy
pseudoprogression
ctla-4
pd-1
pd-l1 inhibitors
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/087c99ed4f454995bde9965434ae6e7f
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/087c99ed4f454995bde9965434ae6e7f

Similar Items